Andrei Iagaru
Publication Details
-
18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas.
Nucl Med Commun. 2006; (10): 795-802
Sarcomas represent a significant therapeutic challenge and their potential for distant pulmonary metastases is well known. [(18)F]Fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET) has a role in differentiating sarcomas from benign tumours and assessing the response to therapy in advanced sarcomas. However, PET appears to be less accurate in detection of pulmonary metastases. We were therefore prompted to review our experience with PET and PET/computed tomography (CT) in osseous and soft tissue sarcomas (OSTSs).
Help